Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Esophageal Squamous Cell Carcinoma 7 Rectal Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 HER2-positive Breast Cancer 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of External Auditory Canal 1 Seminoma 1 Recurrence 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1

Interventions

Specimen Handling 4 Gemcitabine 3 Doxorubicin 3 liposomal doxorubicin 2 Trabectedin 2 Magnetic Resonance Spectroscopy 2 Dacarbazine 2 Biopsy 2 toripalimab 1 regorafenib 1 peposertib 1 cemiplimab 1 anlotinib 1 abemaciclib 1 X-Rays 1 Tretinoin 1 Tissue Banks 1 Tablets 1 Surgical Procedures, Operative 1 Standard of Care 1 Rosuvastatin Calcium 1 Radiotherapy 1 Quality of Life 1 Nivolumab 1 Neoadjuvant Therapy 1 Midazolam 1 Injections 1 Immunoglobulin G 1 Ifosfamide 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leiomyosarcoma × Neoadjuvant Therapy × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡